The first half of this year did not bring much of a stir in stock trading as a consequence of both the development of the pandemic and the slow recovery of the economy.

However, at the end of June this year, the Bulgarian Stock Exchange had a public company with a market capitalization of more than one billion leva.

The share prices of Tchaikapharma High Quality Medicines AD reflect the business plans and financial results of the company and its market cap is going up. In early July it confirms its position as the most expensive company on the Bulgarian Stock Exchange.

The full article is published in the financial media Banker.